Antioxidant enzyme and malondialdehyde levels in patients with panic disorder

被引:109
|
作者
Kuloglu, M
Atmaca, M
Tezcan, E
Ustundag, B
Bulut, S
机构
[1] Firat Univ, Fac Med, Dept Psychiat, Elazig, Turkey
[2] Firat Univ, Fac Med, Dept Biochem, Elazig, Turkey
[3] Firat Univ, Fac Med, Dept Neurol, Elazig, Turkey
关键词
panic disorder; antioxidant enzyme; malondialdehye;
D O I
10.1159/000067810
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
There is evidence of an etiopathogenetic role of free radicals (FRs) in some neuropsychiatric disorders. The aim of the present study was to determine whether the activity levels of some antioxidant enzymes [glutathione peroxidase (GSH-Px), superoxide dismutase (SOD) and catalase (CAT)] and malondialdehyde (MDA), a product of lipid peroxidation, were associated with panic disorder (PD). Twenty patients diagnosed with PD and 20 healthy controls were enrolled in this study. A clinical evaluation and measurements of GSH-Px SOD, CAT and MDA were performed. Additionally, all patients were assessed by the Panic Agoraphobia Scale (PAS). The mean GSH-Px, SOD and MDA levels of the patient group were significantly higher than those of the controls. There was a significant positive correlation between PAS scores and GSH-Px, SOD and MDA levels and between the duration of illness and SOD, CAT and MDA levels in the patient group. In conclusion, our results suggest that FRs may be involved in PD. Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码:186 / 189
页数:4
相关论文
共 50 条
  • [21] Elevated plasma levels of neuropeptide Y in patients with panic disorder
    Boulenger, JP
    Jerabek, I
    Jolicoeur, FB
    Lavallee, YJ
    Leduc, R
    Cadieux, A
    AMERICAN JOURNAL OF PSYCHIATRY, 1996, 153 (01): : 114 - 116
  • [22] FREE THYROID-HORMONE LEVELS IN PATIENTS WITH PANIC DISORDER
    ADAMS, JR
    WAHBY, VS
    GILLER, EL
    MASON, JW
    PSYCHOSOMATIC MEDICINE, 1985, 47 (03): : 308 - 308
  • [23] Effect of pharmacotherapy on serum cholesterol levels in patients with panic disorder
    Shioiri, T
    Fujii, K
    Someya, T
    Takahashi, S
    ACTA PSYCHIATRICA SCANDINAVICA, 1996, 93 (03) : 164 - 167
  • [24] Cortical GABA levels in panic disorder
    Goddard, AW
    Mason, GF
    Rothman, DL
    Behar, KL
    Charney, DS
    Krystal, JH
    BIOLOGICAL PSYCHIATRY, 1999, 45 (08) : 17S - 17S
  • [25] ARTERIAL EPINEPHRINE LEVELS IN PANIC DISORDER
    PAPP, LA
    MARTINEZ, J
    GORMAN, JM
    PSYCHIATRY RESEARCH, 1988, 25 (01) : 111 - 112
  • [26] PLATELET SEROTONIN LEVELS IN PANIC DISORDER
    BALON, R
    POHL, R
    YERAGANI, V
    RAINEY, J
    OXENKRUG, GF
    ACTA PSYCHIATRICA SCANDINAVICA, 1987, 75 (03) : 315 - 317
  • [27] The effects of fasting on blood antioxidant potential and malondialdehyde levels
    Çimen, MYB
    Kaçmaz, M
    Büyükkoçak, S
    Tüzün, E
    Öztürk, HS
    Durak, I
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 1999, 37 (01) : 83 - 84
  • [28] Increased cholesterol levels after paroxetine treatment in patients with panic disorder
    Kim, EJ
    Yu, BH
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2005, 25 (06) : 597 - 599
  • [29] Levels of adenosine deaminase and dipeptidyl peptidase IV in patients with panic disorder
    Yarpuz, Asli Yolac
    Yilmaz, Ayseguel
    Soykan, Atilla
    Elguen, Serenay
    Kumbasar, Hakan
    TURK PSIKIYATRI DERGISI, 2008, 19 (02) : 149 - 156
  • [30] An association of NAG levels and a mutation of the CCK gene in panic disorder patients
    Garvey, MJ
    Crowe, RR
    Wang, ZW
    PSYCHIATRY RESEARCH, 1998, 80 (02) : 149 - 153